2. UroToday Home
  3. Video Lectures
  4. Clinical Case-Based Learning

Clinical Case-Based Learning VL

Tumor Board Reviewing PSMA PET in the Care of Patient with Gleason 4+4=8 GG 4, 6 Cores on Left, Gleason 4+3=7 GG, 6 Cores on Right Prostate Adenocarcinoma, Session 1 Case 4 - H Jacene, A Kibel, P Nguyen & A Morgans

Tumor Board Reviewing PSMA PET in the Care of Patient with Gleason 4+4=8 GG 4, 6 Cores on Left, Gleason 4+3=7 GG, 6 Cores on Right Prostate Adenocarcinoma, Session 1 Case 4 - H Jacene, A Kibel, P Nguy...

Details
In this Clinical Case-Based Learning Educational Program, a Virtual Tumor Board in Prostate Cancer, a case of a 68-year-old man is presented, evaluated, and his prostate cancer treatment plan is addressed. Independent Medical Education Initiative Supported by Progenics Pharmaceuticals, Inc. a subsidiary of Lantheus Holdings, Inc. Biographies: Heather Jacene, MD, Clinical Director of Nuclear Medici...
Tumor Board Reviewing PSMA PET in the Care of Patient with Gleason 4+5=9, GG 5 Prostate Adenocarcinoma, with an Intraductal Component Session 1 Case 1- H Jacene, A Kibel, P Nguyen & A Morgans

Tumor Board Reviewing PSMA PET in the Care of Patient with Gleason 4+5=9, GG 5 Prostate Adenocarcinoma, with an Intraductal Component Session 1 Case 1- H Jacene, A Kibel, P Nguyen & A Morgans

Details
In this Clinical Case-Based Learning Educational Program, a Virtual Tumor Board in Prostate Cancer, a case of a 76-year-old man with a history of hypertension and an active lifestyle is presented, evaluated, and his treatment plan addressed. Independent Medical Education Initiative Supported by Progenics Pharmaceuticals, Inc. a subsidiary of Lantheus Holdings, Inc. Biographies: Heather Jacene, MD,...
Tumor Board Reviewing Locally Advanced pT3N1M0 Prostate Cancer - CASE 4

Tumor Board Reviewing Locally Advanced pT3N1M0 Prostate Cancer - CASE 4

Details
In this Clinical Case-Based Learning Educational Program, a Virtual Tumor Board in Advanced Prostate Cancer, a case of a 70-year-old man with no past medical history other than locally advanced pT3N1M0 prostate cancer is presented, evaluated, and his treatment plan addressed. Independent Medical Education Initiative Supported by Progenics Pharmaceuticals, Inc. a subsidiary of Lantheus Holdings, In...
Tumor Board Reviewing pT2N0M0 Localized Prostate Cancer - CASE 2

Tumor Board Reviewing pT2N0M0 Localized Prostate Cancer - CASE 2

Details
In this Clinical Case-Based Learning Educational Program, a Virtual Tumor Board in Advanced Prostate Cancer, a case of a 69-year-old With a history of coronary artery disease and localized prostate cancer (pT2N0M0) is presented, evaluated, and his treatment plan addressed. Independent Medical Education Initiative Supported by Progenics Pharmaceuticals, Inc. a subsidiary of Lantheus Holdings, Inc....
Tumor Board Reviewing pT3N1M0 Locally Advanced Prostate Cancer - CASE 1

Tumor Board Reviewing pT3N1M0 Locally Advanced Prostate Cancer - CASE 1

Details
In this Clinical Case-Based Learning Educational Program, a Virtual Tumor Board in Advanced Prostate Cancer, a case of a 71-year-old man with a history of hypertension and locally advanced (pT3N1M0) prostate adenocarcinoma is presented, evaluated, and his treatment plan addressed. Independent Medical Education Initiative Supported by Progenics Pharmaceuticals, Inc. a subsidiary of Lantheus Holding...